Scientific Company Directory
The latest research, products, and discoveries from the science industry’s leading companies and company divisions.
NEW
Scientific Products
From innovative tools to essential equipment and supplies, find everything you need to advance your research on our new Scientific Products page.
Search Scientific Products
For over 55 years, INFORS HT has been developing and producing high-tech solutions for biotechnology, biopharmaceuticals, food technology, agricultural technology, and research institutes worldwide. Our areas of competence cover the entire culture process, from screening to process development to production. We are proud to be one of the best in the field of specialists for bioreactors, shaker incubators and bioprocess control software. Much has changed since the company was founded in 1965. The Spirit of INFORS HT, however, remains the same. In keeping with our company creed— "We firmly believe you can make anything better"—we commit ourselves every day to simplifying our biotechnology customers' workflows using the most modern technologies available.
Infinity Bio is a technology company that provides detailed insights into the immune system using its proprietary core technology that comprehensively measures the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins.
Infinity's assay, MIPSA, was developed at Johns Hopkins University in Ben Larman's Lab of Precision Immunology. It builds off decades of work in the fields of genomics, proteomics, immunology, and bioinformatics. Infinity Bio's assay was engineered to enable best-in-class quality, turnaround times and cost.
Inpeco Group designs, develops, manufactures and distributes solutions for the complete automation and traceability of specimens in Clinical Laboratories, thus granting a seamless chain of custody for the entire process, from blood drawing to results validation. Inpeco has built its expertise in 25+ years, providing Automation solutions to 1600 labs, in over 60 countries.
iPRECIO
Our Mission
Create true Value for our Life science Customers
iPRECIO SMP-200 - (rats or larger)
Make it as easy as possible to evaluate efficacy of molecules/agents in-vivo in different animal models and species.
Make the results as relevant as possible to the clinic. (Exposure profile, quantitative pharmacology, ...)
The use of iPRECIO® pumps will have a positive impact on experimental
conditions and the relevance of results achieved. Initial costs maybe higher
but in the long run the use of the pump could be cost saving in the context of the whole compound development.
http://www.iprecio.com/
iPRECIO® is a trademark of Primetech Corporation.
About Primetech
We are a manufacturer and distributor of high technology lifescience research equipment throughout Japan for more than 25 years. We have technically advanced staffs, and an intimate knowledge of the Japanese marketplace allow it to assist companies in penetrating the Japanese market.
http://www.primetech.co.jp/english/partners/tabid/112/language/en-US/Default.aspx
The ICFA is a broad group of Cannabis farmers, scientists, and stakeholders working together to promote the unique quality and ecological benefits of traditionally farmed Cannabis and Cannabis-derived products while preserving the heritage of traditional farming communities.
Internationally, regulatory frameworks often require that therapeutic Cannabis varietals be grown indoors or in all season greenhouses despite the overwhelming evidence that traditionally farmed sun grown Cannabis is qualitatively and ecologically superior. This public policy trend has devastating environmental implications and leaves both patients and adult-use consumers without access to traditionally farmed sun grown cannabis and cannabis-derived products.
We have formed the International Cannabis Farmers Association to establish the science, data and consumer direct education necessary to break down these barriers while promoting the health and environmental benefits of traditionally farmed sun grown Cannabis.
As individuals, our power is limited. As a group, we are far more powerful.
At Intermountain Precision Genomics we use a revolutionary method of gene sequencing. Our experts now deliver more precise medicine than ever before and are on the forefront of personalized cancer testing for all types of genetic mutations. Our process is unique because we offer a Molecular Tumor Board review as a part of every test. This team approach gives community oncologists confidence in providing the best options for patients. Drug procurement is also available and clinical trial information is included in the results. We are providing these treatments to patients across the nation, giving more people a better quality of life.
INTEGRA is a leading provider of high quality laboratory tools and consumables for liquid handling. We are committed to fulfilling the needs of laboratory professionals in research, diagnostics and quality control within the life sciences industry. Visit www.integra-biosciences.com to see the full line of our innovative products.
Founded in 1971, Instech Laboratories, Inc. is a privately-owned company focused on the design, development and manufacturing of instruments for biomedical research. The majority of Instech's business comes from a range of products that evolved from the founder's experience in basic medical sciences, including laboratory animal infusion systems, dissolved oxygen monitors and miniature stirring systems.
InSphero provides 3D cell culture technology and tumor microtissue screening services for the cancer research industry. Our assay-ready 3D InSight™ Tumor Microtissues, scaffold-free GravityPLUS™ Hanging Drop System and GravityTRAP™ ULA Plates, 3D optimized assays, and SCREEN Cell3iMager enable more relevant & predictive in vitro efficacy testing and phenotypic screening.
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.
Inscripta is developing the world's first benchtop platform for scalable digital genome engineering. The company's advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale. Inscripta's goal is to empower scientists whose gene editing research is stifled by current technical and licensing limitations. By providing this unique platform and engaging in collaborative business practices, such as making its MAD7™ CRISPR nuclease free for research and development purposes, the company enables scientists to realize a new era of biological discovery. Headquartered in Boulder, Colo., with offices in Pleasanton, Calif., and San Diego, Inscripta is backed by leading investors including Venrock, Foresite, Paladin Capital Group, Mérieux Développement, NanoDimension, MLS Capital, JS Capital Management LLC, and Oak HC/FT. For more information, visit www.inscripta.com.
Inscopix is a discovery-phase neuroscience company in Palo Alto, CA. Inscopix is pursuing a rigorous science-centric approach to technological innovation for brain activity mapping, creating unprecedented opportunities for advancing fundamental brain research and the development of treatments for brain disorders such as Alzheimer's, schizophrenia, and Autism.
Today, Inscopix is best known for its miniaturized microscope technology, nVista, and data analysis software, Mosaic, that enable imaging and interpretation of large-scale neural activity at cellular resolution during naturalistic animal behavior.
Inscopix's technology has been deployed in over a hundred laboratories across the globe (including 6 Nobelist and 23 HHMI laboratories) and is powering key insights into the neural-circuit basis of diverse mental functions and behavioral states.
Inscopix is an industry partner of the Presidential BRAIN Initiative and was recently recognized by the World Economic Forum as a Technology Pioneer 2015.
